Combination of lipid metabolism alterations and their sensitivity to inflammatory cytokines in human lipin-1-deficient myoblasts

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 12, 2013, Pages 2103-2114

  Michot, Caroline ^a   Mamoune, Asmaa ^a   Vamecq, Joseph ^b   Viou, Mai Thao ^c   Hsieh, Lu Sheng ^d   Testet, Eric ^e   Lainé, Jeanne ^f   Hubert, Laurence ^a   Dessein, Anne Frédérique ^b   Fontaine, Monique ^b   Ottolenghi, Chris ^a   Fouillen, Laetitia ^e   Nadra, Karim ^b   Blanc, Etienne ^g   Bastin, Jean ^g   Candon, Sophie ^b   Pende, Mario ^b   Munnich, Arnold ^a   Smahi, Asma ^a   Djouadi, Fatima ^g   Carman, George M ^d   Romero, Norma ^c   de Keyzer, Yves ^a   de Lonlay, Pascale ^a   more..

^a IMAGINE INSTITUTE   (France)

^b INSERM   (France)

^c CNRS   (France)

^d RUTGERS UNIVERSITY   (United States)

^e University Victor Segalen   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

ACACB; Inflammation; Lipid droplet; Lipin 1; PAP1; Rhabdomyolysis

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DEHYDROGENASE; CARNITINE; CARNITINE PALMITOYLTRANSFERASE; CARNITINE PALMITOYLTRANSFERASE 1B; CARNITINE PALMITOYLTRANSFERASE 2; FAT DROPLET; FATTY ACID; INTERLEUKIN 1BETA; LIPIN 2 PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHATIDATE PHOSPHATASE; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; ENERGY METABOLISM; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPID STORAGE; LIPIN 1 DEFICIENCY; MICROARRAY ANALYSIS; MYOBLAST; MYOTUBE; OXIDATION; PATIENT; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SENSITIVITY ANALYSIS; TRANSCRIPTOMICS; UPREGULATION;

EID: 84883420804     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.07.021     Document Type: Article

References (60)

1. Michot C., Hubert L., Brivet M., De Meirleir L., Valayannopoulos V., Muller-Felber W., Venkateswaran R., Ogier H., Desguerre I., Altuzarra C., Thompson E., Smitka M., Huebner A., Husson M., Horvath R., Chinnery P., Vaz F.M., Munnich A., Elpeleg O., Delahodde A., de Keyzer Y., de Lonlay P. LPIN1 gene mutations: a major cause of severe rhabdomyolysis in early childhood. Hum. Mutat. 2010, 31:E1564-E1573.
2. Zeharia A., Shaag A., Houtkooper R.H., Hindi T., de Lonlay P., Erez G., Hubert L., Saada A., de Keyzer Y., Eshel G., Vaz F.M., Pines O., Elpeleg O. Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood. Am. J. Hum. Genet. 2008, 83:489-494.
3. Harris T.E., Finck B.N. Dual function lipin proteins and glycerolipid metabolism. Trends Endocrinol. Metab. 2011, 22:226-233.
4. Ugrankar R., Liu Y., Provaznik J., Schmitt S., Lehmann M. Lipin is a central regulator of adipose tissue development and function in Drosophila melanogaster. Mol. Cell. Biol. 2011, 31:1646-1656.
5. Han G.S., Carman G.M. Characterization of the human LPIN1-encoded phosphatidate phosphatase isoforms. J. Biol. Chem. 2010, 285:14628-14638.
6. Sugden M.C., Caton P.W., Holness M.J. PPAR control: it's SIRTainly as easy as PGC. J. Endocrinol. 2010, 204:93-104.
7. Mitra M.S., Schilling J.D., Wang X., Jay P.Y., Huss J.M., Su X., Finck B.N. Cardiac lipin 1 expression is regulated by the peroxisome proliferator activated receptor gamma coactivator 1alpha/estrogen related receptor axis. J. Mol. Cell. Cardiol. 2011, 51:120-128.
8. Peterson T.R., Sengupta S.S., Harris T.E., Carmack A.E., Kang S.A., Balderas E., Guertin D.A., Madden K.L., Carpenter A.E., Finck B.N., Sabatini D.M. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 2011, 146:408-420.
9. Finck B.N., Gropler M.C., Chen Z., Leone T.C., Croce M.A., Harris T.E., Lawrence J.C., Kelly D.P. Lipin 1 is an inducible amplifier of the hepatic PGC-1alpha/PPARalpha regulatory pathway. Cell Metab. 2006, 4:199-210.
10. Kim H.B., Kumar A., Wang L., Liu G.H., Keller S.R., Lawrence J.C., Finck B.N., Harris T.E. Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors. Mol. Cell. Biol. 2010, 30:3126-3139.
11. Donkor J., Sariahmetoglu M., Dewald J., Brindley D.N., Reue K. Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns. J. Biol. Chem. 2007, 282:3450-3457.
12. Harris T.E., Huffman T.A., Chi A., Shabanowitz J., Hunt D.F., Kumar A., Lawrence J.C. Insulin controls subcellular localization and multisite phosphorylation of the phosphatidic acid phosphatase, lipin 1. J. Biol. Chem. 2007, 282:277-286.
13. Dwyer J.R., Donkor J., Zhang P., Csaki L.S., Vergnes L., Lee J.M., Dewald J., Brindley D.N., Atti E., Tetradis S., Yoshinaga Y., De Jong P.J., Fong L.G., Young S.G., Reue K. Mouse lipin-1 and lipin-2 cooperate to maintain glycerolipid homeostasis in liver and aging cerebellum. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(37):E2486-E2495.
14. Liu L., Shi X., Choi C.S., Shulman G.I., Klaus K., Nair K.S., Schwartz G.J., Zhang Y., Goldberg I.J., Yu Y.H. Paradoxical coupling of triglyceride synthesis and fatty acid oxidation in skeletal muscle overexpressing DGAT1. Diabetes 2009, 58:2516-2524.
15. Yao-Borengasser A., Rasouli N., Varma V., Miles L.M., Phanavanh B., Starks T.N., Phan J., Spencer H.J., McGehee R.E., Reue K., Kern P.A. Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation. Diabetes 2006, 55:2811-2818.
16. Donkor J., Sparks L.M., Xie H., Smith S.R., Reue K. Adipose tissue lipin-1 expression is correlated with peroxisome proliferator-activated receptor alpha gene expression and insulin sensitivity in healthy young men. J. Clin. Endocrinol. Metab. 2008, 93:233-239.
17. Rehnmark S., Giometti C.S., Slavin B.G., Doolittle M.H., Reue K. The fatty liver dystrophy mutant mouse: microvesicular steatosis associated with altered expression levels of peroxisome proliferator-regulated proteins. J. Lipid Res. 1998, 39:2209-2217.
18. Phan J., Peterfy M., Reue K. Lipin expression preceding peroxisome proliferator-activated receptor-gamma is critical for adipogenesis in vivo and in vitro. J. Biol. Chem. 2004, 279:29558-29564.
19. Phan J., Reue K. Lipin, a lipodystrophy and obesity gene. Cell Metab. 2005, 1:73-83.
20. Michot C., Hubert L., Romero N.B., Gouda A., Mamoune A., Mathew S., Kirk E., Viollet L., Rahman S., Bekri S., Peters H., McGill J., Glamuzina E., Farrar M., von der Hagen M., Alexander I.E., Kirmse B., Barth M., Laforet P., Benlian P., Munnich A., Jeanpierre M., Elpeleg O., Pines O., Delahodde A., de Keyzer Y., de Lonlay P. Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgia. J. Inherit. Metab. Dis. 2012, 35(6):1119-1128.
21. Higashida K., Higuchi M., Terada S. Potential role of lipin-1 in exercise-induced mitochondrial biogenesis. Biochem. Biophys. Res. Commun. 2008, 374:587-591.
22. Djouadi F., Aubey F., Schlemmer D., Bastin J. Peroxisome proliferator activated receptor delta (PPARdelta) agonist but not PPARalpha corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells. J. Clin. Endocrinol. Metab. 2005, 90:1791-1797.
23. Gallucci S., Provenzano C., Mazzarelli P., Scuderi F., Bartoccioni E. Myoblasts produce IL-6 in response to inflammatory stimuli. Int. Immunol. 1998, 10:267-273.
24. Castle J.C., Hara Y., Raymond C.K., Garrett-Engele P., Ohwaki K., Kan Z., Kusunoki J., Johnson J.M. ACC2 is expressed at high levels in human white adipose and has an isoform with a novel N-terminus [corrected]. PLoS One 2009, 4:e4369.
25. Testet E., Laroche-Traineau J., Noubhani A., Coulon D., Bunoust O., Camougrand N., Manon S., Lessire R., Bessoule J.J. Ypr140wp, 'the yeast tafazzin', displays a mitochondrial lysophosphatidylcholine (lyso-PC) acyltransferase activity related to triacylglycerol and mitochondrial lipid synthesis. Biochem. J. 2005, 387:617-626.
26. Fontaine M., Dessein A.F., Douillard C., Dobbelaere D., Brivet M., Boutron A., Zater M., Mention-Mulliez K., Martin-Ponthieu A., Vianey-Saban C., Briand G., Porchet N., Vamecq J. A novel mutation in CPT1A resulting in hepatic CPT deficiency. J. Inherit. Metab. Dis. Rep. 2012, 1:7-14.
27. Dessein A.F., Fontaine M., Dobbelaere D., Mention-Mulliez K., Martin-Ponthieu A., Briand G., Vamecq J. Deuterated palmitate-driven acylcarnitine formation by whole-blood samples for a rapid diagnostic exploration of mitochondrial fatty acid oxidation disorders. Clin. Chim. Acta 2009, 406:23-26.
28. Liu G.H., Gerace L. Sumoylation regulates nuclear localization of lipin-1alpha in neuronal cells. PLoS One 2009, 4:e7031.
29. Fu S., Watkins S.M., Hotamisligil G.S. The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab. 2012, 15:623-634.
30. Smale S.T. Selective transcription in response to an inflammatory stimulus. Cell 2010, 140:833-844.
31. Saggerson D. Malonyl-CoA, a key signaling molecule in mammalian cells. Annu. Rev. Nutr. 2008, 28:253-272.
32. Abu-Elheiga L., Oh W., Kordari P., Wakil S.J. Acetyl-CoA carboxylase 2 mutant mice are protected against obesity and diabetes induced by high-fat/high-carbohydrate diets. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:10207-10212.
33. Farese R.V., Walther T.C. Lipid droplets finally get a little R-E-S-P-E-C-T. Cell 2009, 139:855-860.
34. Xu N., Zhang S.O., Cole R.A., McKinney S.A., Guo F., Haas J.T., Bobba S., Farese R.V., Mak H.Y. The FATP1-DGAT2 complex facilitates lipid droplet expansion at the ER-lipid droplet interface. J. Cell Biol. 2012, 198:895-911.
35. Peterfy M., Phan J., Xu P., Reue K. Lipodystrophy in the fld mouse results from mutation of a new gene encoding a nuclear protein, lipin. Nat. Genet. 2001, 27:121-124.
36. Hu M., Yin H., Mitra M.S., Liang X., Ajmo J.M., Nadra K., Chrast R., Finck B.N., You M. Hepatic-specific lipin-1 deficiency exacerbates experimental alcohol-induced steatohepatitis in mice. Hepatology 2013, (Electronic publication ahead of print, 20th of June).
37. Kok B.P., Kienesberger P.C., Dyck J.R., Brindley D.N. Relationship of glucose and oleate metabolism to cardiac function in lipin-1 deficient (fld) mice. J. Lipid Res. 2012, 53:105-118.
38. Kanicky J.R., Shah D.O. Effect of degree, type, and position of unsaturation on the pKa of long-chain fatty acids. J. Colloid Interface Sci. 2002, 256:201-207.
39. Beopoulos A., Nicaud J.M., Gaillardin C. An overview of lipid metabolism in yeasts and its impact on biotechnological processes. Appl. Microbiol. Biotechnol. 2011, 90:1193-1206.
40. Beopoulos A., Mrozova Z., Thevenieau F., Le Dall M.T., Hapala I., Papanikolaou S., Chardot T., Nicaud J.M. Control of lipid accumulation in the yeast Yarrowia lipolytica. Appl. Environ. Microbiol. 2008, 74:7779-7789.
41. Adeyo O., Horn P.J., Lee S., Binns D.D., Chandrahas A., Chapman K.D., Goodman J.M. The yeast lipin orthologue Pah1p is important for biogenesis of lipid droplets. J. Cell Biol. 2011, 192:1043-1055.
42. Valdearcos M., Esquinas E., Meana C., Gil-de-Gomez L., Guijas C., Balsinde J., Balboa M.A. Subcellular localization and role of lipin-1 in human macrophages. J. Immunol. 2011, 186:6004-6013.
43. Gathercole L.L., Morgan S.A., Bujalska I.J., Hauton D., Stewart P.M., Tomlinson J.W. Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue. PLoS One 2011, 6:e26223.
44. Manmontri B., Sariahmetoglu M., Donkor J., Bou Khalil M., Sundaram M., Yao Z., Reue K., Lehner R., Brindley D.N. Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically. J. Lipid Res. 2008, 49:1056-1067.
45. Law L.K., Tang N.L., Hui J., Ho C.S., Ruiter J., Fok T.F., Wanders R.J., Lam C.W. A novel functional assay for simultaneous determination of total fatty acid beta-oxidation flux and acylcarnitine profiling in human skin fibroblasts using (2)H(31)-palmitate by isotope ratio mass spectrometry and electrospray tandem mass spectrometry. Clin. Chim. Acta 2007, 382:25-30.
46. Zhao L.F., Iwasaki Y., Zhe W., Nishiyama M., Taguchi T., Tsugita M., Kambayashi M., Hashimoto K., Terada Y. Hormonal regulation of acetyl-CoA carboxylase isoenzyme gene transcription. Endocr. J. 2010, 57:317-324.
47. Bergounioux J., Brassier A., Rambaud C., Bustarret O., Michot C., Hubert L., Arnoux J.B., Laquerriere A., Bekri S., Galene-Gromez S., Bonnet D., Hubert P., de Lonlay P. Fatal rhabdomyolysis in 2 children with LPIN1 mutations. J. Pediatr. 2012, 160:1052-1054.
48. Sharma S., Adrogue J.V., Golfman L., Uray I., Lemm J., Youker K., Noon G.P., Frazier O.H., Taegtmeyer H. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. FASEB J. 2004, 18:1692-1700.
49. Santos-Rosa H., Leung J., Grimsey N., Peak-Chew S., Siniossoglou S. The yeast lipin Smp2 couples phospholipid biosynthesis to nuclear membrane growth. EMBO J. 2005, 24:1931-1941.
50. Golden A., Liu J., Cohen-Fix O. Inactivation of the C. elegans lipin homolog leads to ER disorganization and to defects in the breakdown and reassembly of the nuclear envelope. J. Cell Sci. 2009, 122:1970-1978.
51. Lu B., Lu Y., Moser A.H., Shigenaga J.K., Grunfeld C., Feingold K.R. LPS and proinflammatory cytokines decrease lipin-1 in mouse adipose tissue and 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 2008, 295:E1502-E1509.
52. Feingold K.R., Moser A., Patzek S.M., Shigenaga J.K., Grunfeld C. Infection decreases fatty acid oxidation and nuclear hormone receptors in the diaphragm. J. Lipid Res. 2009, 50:2055-2063.
53. Spate U., Schulze P.C. Proinflammatory cytokines and skeletal muscle. Curr. Opin. Clin. Nutr. Metab. Care 2004, 7:265-269.
54. Ostrowski K., Rohde T., Asp S., Schjerling P., Pedersen B.K. Chemokines are elevated in plasma after strenuous exercise in humans. Eur. J. Appl. Physiol. 2001, 84:244-245.
55. Chen X., Xun K., Chen L., Wang Y. TNF-alpha, a potent lipid metabolism regulator. Cell Biochem. Funct. 2009, 27:407-416.
56. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 2006, 116:1494-1505.
57. Pacheco P., Vieira-de-Abreu A., Gomes R.N., Barbosa-Lima G., Wermelinger L.B., Maya-Monteiro C.M., Silva A.R., Bozza M.T., Castro-Faria-Neto H.C., Bandeira-Melo C., Bozza P.T. Monocyte chemoattractant protein-1/CC chemokine ligand 2 controls microtubule-driven biogenesis and leukotriene B4-synthesizing function of macrophage lipid bodies elicited by innate immune response. J. Immunol. 2007, 179:8500-8508.
58. Kobayashi M.A., Watada H., Kawamori R., Maeda S. Overexpression of acetyl-coenzyme A carboxylase beta increases proinflammatory cytokines in cultured human renal proximal tubular epithelial cells. Clin. Exp. Nephrol. 2010, 14:315-324.
59. Ferguson P.J., Chen S., Tayeh M.K., Ochoa L., Leal S.M., Pelet A., Munnich A., Lyonnet S., Majeed H.A., El-Shanti H. Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J. Med. Genet. 2005, 42:551-557.
60. Valdearcos M., Esquinas E., Meana C., Pena L., Gil-de-Gomez L., Balsinde J., Balboa M.A. Lipin-2 reduces proinflammatory signaling induced by saturated fatty acids in macrophages. J. Biol. Chem. 2012, 287:10894-10904.